Clinical Trial Update: HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating HBV-specific TCR-T cell therapy in combination with nucleos(t)ide analogues for chronic hepatitis B. The study is currently recruiting …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HBV-specific TCR-T cell therapy
• Nucleos(t)ide analogue(s)

Snippet

Sponsor: Changhai Hospital | Conditions: Chronic Hepatitis b | Phase 1 | Status: RECRUITING